Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis

The Lancet Oncology

Volumn 12, Issue 7, 2011, Pages 681-692

  Sjoquist, Katrin M ^a   Burmeister, Bryan H ^b   Smithers, B Mark ^b,c   Zalcberg, John R ^d   Simes, R John ^a   Barbour, Andrew ^b,c   Gebski, Val ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; PACLITAXEL; VINBLASTINE; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DRUG EFFECT; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; HUMAN; META ANALYSIS; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

ANTINEOPLASTIC AGENTS; AUSTRALIA; CARCINOMA, SQUAMOUS CELL; DATABASES AS TOPIC; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT;

EID: 79959572435     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70142-5     Document Type: Article

References (51)

1. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009, 27:5062-5067.
2. Mariette C, Piessen G, Triboulet J-P Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007, 8:545-553.
3. Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003, 21:4592-4596. for the Japan Clinical Oncology Group.
4. Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 2005, 4. CD001799.
5. Zieren HU, Müller JM, Jacobi CA, Pichlmaier H, Müller RP, Staar S Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995, 19:444-449.
6. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007, 8:226-234.
7. Ychou M, Boige V, Pignon J-P, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011, 29:1715-1721.
8. Kelsen DP, Winter KA, Gunderson LL, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007, 25:3719-3725.
9. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992, 16:1104-1109.
10. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994, 73:1779-1784.
11. Mariette C, Seitz JF, Maillard E, et al. Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901. Proc Am Soc Clin Oncol 2010, 28(15 suppl):4005. (abstr).
12. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997, 337:161-167.
13. Walsh T The role of multimodality therapy in improving survival: a prospective randomised trial. Predicting, defining and improving outcomes for oesophageal carcinoma [MD thesis] 1995, 124-150. Trinity College, University of Dublin, Dublin.
14. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335:462-467.
15. Burmeister B, Thomas JM, Burmeister EA, et al. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer 2011, 47:354-360.
16. Tepper JE, Krasna M, Niedzwiecki D, et al. Superiority of trimodality therapy to surgery alone in esophageal cancer: results of CALGB 9781. Proc Am Soc Clin Oncol 2006, 24(18 suppl):4012. (abstr).
17. Lee JL, Park SI, Kim SB, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004, 15:947-954.
18. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009, 27:851-856.
19. Schlag PM Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992, 127:1446-1450.
20. Law S, Fok M, Chow S, Chu KM, Wong J Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997, 114:210-217.
21. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001, 91:2165-2174.
22. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005, 6:659-668. for the Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group.
23. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988, 96:242-248.
24. Maipang T, Vasinanukorn P, Petpichetchian C, et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994, 56:191-197.
25. Wang C, Ding T, Chang L [A randomized clinical study of preoperative chemotherapy for esophageal carcinoma]. Zhonghua Zhong Liu Za Zhi 2001, 23:254-255. (in Chinese).
26. Baba M, Natsugoe S, Shimada M, et al. Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 2000, 13:136-141.
27. Natsugoe S, Okumura H, Matsumoto M, et al. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 2006, 19:468-472.
28. Kok T, Lanschot J, Siersema P, et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997, 16:277a. (abstr 984).
29. Parmar MK, Torri V, Stewart L Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.
30. Gleser LJ, Olkin I Models for estimating the number of unpublished studies. Stat Med 1996, 15:2493-2507.
31. Fisher R Statistical methods for research workers 1932, Oliver and Boyd, London. 4th edn.
32. Song F, Altman DG, Glenny A-M, Deeks JJ Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003, 326:472.
33. Peng L, Xie TP, Han YT, et al. Randomized controlled study on preoperative concurrent chemoradiotherapy versus surgery alone for esophageal squamous cell carcinoma. Zhongliu 2008, 28:620-622.
34. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355:11-20.
35. Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954. J Clin Oncol 2010, 28:5210-5218.
36. Bokhyan V, Stilidi I, Malikhova O, Tryakin A 6553 Neoadjuvant chemotherapy followed by transthoracic resection for locally advanced carcinoma of the esophagus: a randomized study. EJC Suppl 2009, 7:377.
37. Boonstra JJ, Kok T, Wijnhoven BPL, et al. Chemotherapy followed by surgery versus surgery alone in patients with oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer 2011, published online May 19. 10.1186/1471-2407-11-181.
38. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002, 359:1727-1733. Medical Research Council Oesophageal Cancer Working Group.
39. Apinop C, Puttisak P, Preecha N A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994, 41:391-393.
40. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001, 19:305-313.
41. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol 2010, 16:1649-1654.
42. van der Gaast A, van Hagen P, Hulshof M, et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study. Proc Am Soc Clin Oncol 2010, 28(15 suppl):4004. (abstr).
43. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008, 26:1086-1092.
44. Rosa AR, Gurski RR, Schirmer CC, Brentano L, Kruel CD Survival and prognostic factors in patients with resected epidermoid oesophageal carcinoma. Int Surg 1999, 84:193-198.
45. Greene FL, Page DL, Fleming ID, et al. Esophagus. AJCC Cancer Staging Manual, 6th edn. American Joint Committee on Cancer 2002, 91-98. Springer, New York, NY.
46. Bosset J-F, Gignoux M, Triboulet J-P, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997, 337:161-167.
47. Staal E, Aleman BMP, Boot H, van Velthuysen MLF, van Tinteren H, van Sandick JW Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 2010, 97:1482-1496.
48. Wijnhoven BP, van Lanschot JJ, Tilanus HW, Steyerberg EW, van der Gaast A Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses. World J Surg 2009, 33:2606-2614.
49. Smit JK, Pultrum BB, van Dullemen HM, Van Dam GM, Groen H, Plukker JT Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy. Am J Surg 2010, 200:446-453.
50. Solomon N, Zhuge Y, Cheung M, Franceschi D, Koniaris LG The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol 2010, 17:791-803.
51. Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al. Meta-analysis of preoperative chemotherapy (CTX) versus primary surgery for locoregionally advanced adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus (GE adenocarcinoma). Proc Am Soc Clin Oncol 2010, 28(suppl). abstr 4022.